Evaluating the cost of therapy for restenosis: Considerations for brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 4, 1996, Pages 949-958

  Weintraub, William S ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Cost; Microeconomics; Outcomes; Restenosis; Utility

Indexed keywords

ARTICLE; BRACHYTHERAPY; CORONARY ARTERY OBSTRUCTION; COST BENEFIT ANALYSIS; COST UTILITY ANALYSIS; HUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

BRACHYTHERAPY; CORONARY DISEASE; COST OF ILLNESS; COSTS AND COST ANALYSIS; FEES, MEDICAL; FORECASTING; HEALTH CARE COSTS; HOSPITAL COSTS; HUMANS; MODELS, ECONOMIC; RECURRENCE; RELATIVE VALUE SCALES; TREATMENT OUTCOME; UNITED STATES;

EID: 0030293675     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00413-0     Document Type: Article

References (39)

1. 1. Alchian, A. The meaning of utility measurement. Am. Econ. Rev. 43:26-50; 1953.
2. 2. Baim, D. S.; Kent, K. M.; King, S. B., III; Safian, R. D.; Cowley, M. J.; Holmes, D. R.; Roubin, G. S.; Gallup, D.; Steenkiste, A. R.; Detre, K. Evaluating new devices. Acute (in-hospital) results from the New Approaches to Coronary Intervention Registry. Circulation 89:471-481; 1994.
3. 3. Becker, E. R.; Dunn, D.; Hsiao, W. C. Relative cost differences among physicians' specialty practices. JAMA 260:2397-2402; 1988.
4. 4. Becker, E. R.; Mauldin, P. D.; Weintraub, W. S.; King, S. B. III. Physician profiles or coronary revascularization in the Emory Angioplasty vs. Surgery Trial: Understanding physician differences using resource-based relative values. J. Am. Coll. Cardiol. 25:344A; 1995 (abstr).
5. 5. Churchill, D. N.; Morgan, J.; Torrance, G. W. Quality of life in end-stage renal disease. Perit. Dial. Bull. 4:20-23; 1984.
6. 6. Cohen, D. J.; Krumholz, H. M.; Sukin, C. A.; Ho, K. K. L.; Siegrist, R. B.; Cleman, M.; Heuser, R. R.; Brinker, J. A.; Moses, J. W.; Savage, M. P.; Detre, K.; Leon, M. B.; Baim, D. S.; for the Stent Restenosis Study Investigators In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: Results from a randomized clinical trial. Circulation 92:2480-2487; 1995.
7. 7. Cook, P. J.; Graham, D. A. The demand for insurance and protection: The case of irreplaceable commodities. Q. J. Econ. 91:143-156; 1977.
8. 8. Cooper, R.; Kaplan, R. S. Measure costs right: Make the right decisions. Harvard Business Rev. 5:96-103; 1988.
9. 9. Dearden, J. Cost accounting comes to service industries. Harvard Business Rev. September-October:132-140; 1978.
10. 10. Drummond, M. F.; Stoddart, G. L.; Torrance, G. W. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 1990.
11. 11. Feldstein, P. J. Health care economics, 2nd ed. New York: Wiley; 1983:169-197.
12. 12. Ferguson, C. E. Microeconomic theory. 6th ed. Homewood, IL: Richard D. Irwin; 1968.
13. 13. Finkler, S. A. The distinction between cost and charges. Ann. Intern. Med. 96:102-109; 1982.
14. 14. Finkler, S. A. Cost finding for high-technology, high cost services. Health Care Manage. Rev. 5:17-29; 1980.
15. 15. Fischman, D. L.; Leon, M. B.; Baim, D. S.; Schatz, R. A.; Savage, M. P.; Penn, I.; Detre, K.; Veltri, L.; Ricci, D.; Nobuyoshi, M.; Cleman, M.; Heuser, R.; Almond, D.; Teirstein, P. S.; Fish, R. D.; Colombo, A.; Brinker, J.; Moses, J.; Shaknovich, A.; Hirshfeld, J.; Bailey, S.; Ellis, S.; Rake, R.; Goldberg, S.; for the Stent Restenosis Study Investigators A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N. Engl. J. Med. 331:496-501; 1994.
16. 16. Fuchs, V. R.; Zeckhauser, R. Valuing health - A "priceless" commodity. Am. Econ. Rev. 77:263-268; 1987.
17. 17. Gilbert, S. P.; Weintraub, W. S.; Talley, J. D.; Boccuzzi, S. J.; for the Lovastatin Restenosis Group The costs of restenosis (Lovastatin Restenosis Trial). Am. J. Cardiol. 77:196-199; 1996.
18. 18. Graham, D. A. Cost-benefit analysis under uncertainty. Am. Econ. Rev. 71:715-725; 1981.
19. 19. Harsanyi, J. C. Cardinal welfare, individualistic ethics, and interpersonal comparisons of utility. J. Pol. Econ. 63:309-321; 1995.
20. 20. Hlatky, M. A.; Lipscomb, J.; Nelson, C.; Califf, R. M.; Pryor, D.; Wallace, A. G.; Mark, D. B. Resource use and cost of initial coronary revascularization: Coronary angioplasty vs. coronary bypass surgery. Circulation 82(Suppl. IV):IV-208-IV-213; 1990.
21. 21. Hsiao, W. C.; Braun, P.; Yntema, D.; Becker, E. R. Estimating physicians' work for a resource-based relative value scale. N. Engl. J. Med. 319:835-841; 1988.
22. 22. Joreskog, K. G.; Goldberger, A. S. Estimation of a model with multiple indicators and multiple cause of a single latent variable. J. Am. Stat. Assoc. 70:631-639; 1975.
23. 23. Kaplan, R. M.; Bush, J. W.; Berry, C. C. Health status: Types of validity of the index of well-being. Health Serv. Res. 11:478-507; 1976.
24. 24. King, S. B., III; Lembo, N. J.; Weintraub, W. S.; Kosinski, A. S.; Barnhart, H. X.; Kutner, M. H.; Alazraki, N. P.; Guyton, R. A.; Zhao, X. Q. A randomized trial comparing coronaryangioplasty with coronary bypass surgery: The Emory Angioplasty vs. Surgery Trial. N. Engl. J. Med. 331:1044-1050; 1994.
25. 25. Loomes, G.; McKenzie, L. The use of QALYs in health care decision making. Soc. Sci. Med. 28:299-308; 1989.
26. 26. Machina, M. J. Choice under uncertainty: Problems solved and unsolved. J. Econ. Perspect. 1:121-154; 1987.
27. 27. McNeil, B. J.; Weichselbaum, R.; Pauker, S. G. Speech and survival: Tradeoffs between quality and quantity of life in laryngeal cancer. N. Engl. J. Med. 305:982-987; 1981.
28. 28. Pliskin, J. S.; Shepard, D. S.; Weinstein, M. C. Utility functions for life years and health status. Operations Res. 28:206-224; 1980.
29. 29. Sackett, D. L.; Torrance, G. W. The utility of different health states as perceived by the general public. J. Chronic Dis. 31:697-704; 1978.
30. 30. Shuman, J.; Wolfe, H.; Perlman, M. Model for hospital microcosting. Indust. Eng. :39-43; 1973.
31. 31. Source Book of Health Insurance Data, 1991. Washington, DC: Health Insurance Association of America; 1991:55.
32. 32. Spertus, J. A.; Winder, J. A.; Dewhurst, T. A.; Deyo, R. A.; Fihn, S. D. Monitoring quality of life in patients with coronary artery disease. Am. J. Cardiol. 74:1240-1244; 1994.
33. 33. Topol, E. J.; Leya, F.; Pinkerton, C. A.; Whitlow, P. L.; Hofling, B.; Simonton, C. A.; Masden, R. R.; Serruys, R. W.; Leon, M. B.; Williams, D. O.; King, S. B., III; Mark, K. B.; Isner, J. M.; Holmes, D. R., Jr.; Ellis, S. G.; Lee, K. L.; Keeler, G. P.; Berdan, L. G.; Hinohara, T.; Califf, R. M.; for the CAVEAT Study Group A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N. Engl. J. Med. 329:221-227; 1993.
34. 34. Van De Ven, W. P.; Wynard, P. M. M.; Hooijmans, E. M. The MIMI health status index (what it is and what it does). Economics of health care. Kluwer Academic; 1992:19-29.
35. 35. Van De Ven, W. P.; Wynard, P. M. M.; Van Der Gaag, J. Health as an unobservable: A MIMIC-model of demand for health care. J. Health Econ. 1:157-183; 1982.
36. 36. Weinstein, M. C.; Stason, W. B. Cost effectiveness of coronary artery bypass surgery. Circulation 66(Suppl. III):56-65; 1982.
37. 37. Weintraub, W. S.; Ghazzal, Z. M. B.; Scott, N.; Douglas, J. S., Jr.; Benard, J.; Mauldin, P.; Becker, N.; King, S. B., III. Declining resource utilization in interventional cardiology. Am. J. Managed Care 1:58-63; 1995.
38. 38. Weintraub, W. S.; Mauldin, P. D.; Becker, E. R.; Kosinski, A. S.; King, S. B., III. A comparison of the costs of and quality of life after coronary angioplasty and coronary surgery: Results from the Emory Angioplasty vs. Surgery Trial (EAST). Circulation 92:2831-2840; 1995.
39. 39. Weintraub, W. S.; Waksman, R.; Benard, J.; Hicks, F.; Canup, D.; Becker, E.; Mauldin, P.; King, S. B., III. The influence of new devices on the costs of interventional procedures. Circulation 90:1-44; 1994.